Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

9c1776ab-2ed8-4970-8fa4-95980414dfdf - samples

ABSTRACT: TPM matrices of counts from RNA sequencing (RNAseq) from baseline CD138+ enriched BM fractions.

PROVIDER: EGAD00001011148 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

c6a3480a-34b1-4b1d-bfff-0c323a97217d - samples

Project description:TPM matrices of counts from RNA sequencing (RNAseq) from longitudinal CD138+ enriched BM fractions.

| EGAD00001011144 | EGA

02ed0d5a-d688-4e05-baa4-3a5a5aede403 - samples

Project description:TPM matrices of counts from RNA sequencing (RNAseq) from baseline CD138(Ã¢Â€Â“) BM fractions.

| EGAD00001011142 | EGA

581b8c3f-ee87-4c0c-9e44-5ff751b7cc24 - samples

Project description:TPM matrices of counts from RNA sequencing (RNAseq) from longitudinal CD138(Ã¢Â€Â“) BM fractions.

| EGAD00001011145 | EGA

289a561c-a53e-41af-a150-43a78fd6ce74 - samples

Project description:TPM matrices of counts from RNAseq data for IMvigor010 from bulk pre-treatment tumors.

| EGAD00001007653 | EGA

Transcriptomic analysis of Multiple Myeloma bone marrow microenvironment

Project description:We report the RNA sequencing of the non-tumoral CD138- fractions of 74 MM patient BM aspirates taken at the time of diagnosis.

2019-01-01 | GSE104171 | GEO

8b1e06b6-f298-4d8d-afbc-505c8c1c1555 - samples

Project description:Matrices of TPM-normalized counts from RNAseq data for the three phase II clinical trials (IMvigor210, POPLAR, IMmotion150) and the phase I clinical trial PCD4989g.

| EGAD00001006741 | EGA

e293e036-64d4-4964-8d7b-dda98c392143 - samples

Project description:This dataset contains log2(TPM + 1) transformed counts for the 823 tumor samples profiled by RNAseq.

| EGAD00001006618 | EGA

Integrated spatial transcriptomics (Stereo-seq) and bulk RNA-seq of cardiac sonogenetics in rodent heart tissue across time points [Stereo-seq]

Project description:This GEO Series contains two complementary transcriptomic datasets generated to study cardiac sonogenetics in rodent heart tissue. First, spatial transcriptomics was performed using Stereo-seq (SAW v8.1.3) to generate spatially resolved gene-expression maps from heart sections, providing GEF outputs, tissue images, and associated QC files. Second, bulk RNA-seq was performed on matched heart tissue samples from wild-type (WT) and sonogenetic (MscL-G22S) groups across multiple time points to quantify gene-level expression changes at the whole-tissue level. Raw sequencing files (FASTQ) and processed expression matrices (counts/TPM tables) are provided for both assays. Together, these datasets enable cross-validation of spatially localized transcriptional patterns with bulk gene-expression measurements.

2026-03-17 | GSE324075 | GEO

Integrated spatial transcriptomics (Stereo-seq) and bulk RNA-seq of cardiac sonogenetics in rodent heart tissue across time points [RNA-Seq]

2026-03-17 | GSE324074 | GEO

Interferon activation in bone marrow long-lived plasma cells in systemic lupus erythematosus

Project description:While durable antibody responses from long-lived plasma cell (LLPC) populations are important for protection against pathogens, LLPC may be harmful if they produce antibodies against self-proteins or self-nuclear antigens as occurs in autoimmune diseases such as systemic lupus erythematosus (SLE). Thus, the elimination of autoreactive LLPC may improve the treatment of antibody-driven autoimmune diseases. However, LLPC remain a challenging therapeutic target. Here, we compare the matched bone marrow and blood plasma cell compartments of SLE and healthy donors (HD). We show a similar distribution of CD138- and CD138+ plasma cells (PC), including putative LLPC (CD19- CD138+ CD38+), between SLE and HD bone marrow (BM). For both SLE and HD, CD138+ PC are at a higher frequency in BM than peripheral blood (PBL). Expression of Ki-67 associates with the PBL compartment where it is found on all PC subsets regardless of CD19 or CD138 expression. Transcriptomic analysis identifies an interferon gene signature in transitional B cells in the SLE BM, but surprisingly also in the BM PC derived from SLE. PC phosphorylate STAT1 in response to type I IFN stimulation in vitro. Circulating PC bind type I IFN receptor-blocking antibody anifrolumab, though to a lesser degree than circulating B cells. Anti-nuclear autoantibodies are found in the BM supernatant and PBL serum of SLE patients. SLE BM-derived PC have increased survival compared to their PBL counterparts when treated with selinexor. In summary, these findings show evidence of IFN activation in BM PC from SLE.

2024-12-30 | GSE278120 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data